AstraZeneca
AZN
AZN
1,135 hedge funds and large institutions have $33.7B invested in AstraZeneca in 2024 Q1 according to their latest regulatory filings, with 119 funds opening new positions, 486 increasing their positions, 338 reducing their positions, and 93 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,135
Holders Change
+11
Holders Change %
+0.98%
% of All Funds
16.45%
Holding in Top 10
12
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.69%
% of All Funds
0.17%
New
119
Increased
486
Reduced
338
Closed
93
Calls
$480M
Puts
$470M
Net Calls
+$10M
Net Calls Change
-$43.8M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$610M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$502M |
| 3 |
Neuberger Berman Group
New York
|
+$172M |
| 4 |
Millennium Management
New York
|
+$154M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$150M |
Top Sellers
| 1 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$924M |
| 2 |
Morgan Stanley
New York
|
-$675M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$160M |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$132M |
| 5 |
D.E. Shaw & Co
New York
|
-$105M |
